Some treatment dilemmas in rapidly developing dementia: a case report.
The treatment of rapidly deteriorating dementia is always very challenging. This case report describes a 78-year-old male patient with rapidly developing dementia treated successfully with orally disintegrating olanzapine, memantine, donepezil, omega-3 and vitamin-B complex. The prevailing fatalism and treatment nihilism regarding treatment of dementia should give way to more hope and optimism. Several important treatment dillemas in rapidly developing dementia are discussed.
Jakovljevic
Miro
M
University Psychiatric Clinic, Clinical Hospital Centre Zagreb, Zagreb, Croatia. miro.jakovljevic@mef.hr
Vuksan-Cusa
Bianka
B
Topic
Radmila
R
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D018450:Disease Progression; D000077265:Donepezil; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004569:Electroencephalography; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D000077152:Olanzapine; D010880:Piperidines / Q000627:therapeutic use*; D012720:Severity of Illness Index
D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018491:Dopamine Agonists; D007189:Indans; D010880:Piperidines; D001569:Benzodiazepines; D000077265:Donepezil; D000077152:Olanzapine; D008559:Memantine